Koesten, Hirschmann & Crabtree »

Adaptimmune Therapeutics shares owned by Koesten, Hirschmann & Crabtree

Quarter-by-quarter ownership of Adaptimmune Therapeutics (ADAP) shares owned by Koesten, Hirschmann & Crabtree from 13F filings

Historical chart of Koesten, Hirschmann & Crabtree investment in Adaptimmune Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Adaptimmune Therapeutics held by Koesten, Hirschmann & Crabtree consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Adaptimmune Therapeutics by Koesten, Hirschmann & Crabtree

Quarter filed Position value Share count Share price at filing
2025-09-30 $6 47 0.15
2025-06-30 $11 47 0.26

More positions owned by Koesten, Hirschmann & Crabtree

Schwab Strategic Tr Fundamental Us L (FNDX)
Vanguard Index Fds Large Cap Etf (VV)
Schwab Strategic Tr Intl Eqty Etf (SCHF)
Schwab Strategic Tr Us Lrg Cap Etf (SCHX)
Vanguard Index Fds Small Cp Etf (VB)
Ishares Tr Core Msci Eafe (IEFA)
Ishares Tr Core S&p500 Etf (IVV)
Ishares Core Msci Emkt (IEMG)
Ishares Tr Core S&p Scp Etf (IJR)
Schwab Strategic Tr Us Sml Cap Etf (SCHA)
Schwab Strategic Tr Emrg Mkteq Etf (SCHE)
Apple (AAPL)
Schwab Strategic Tr Us Mid-cap Etf (SCHM)
Ishares Tr Core S&p Mcp Etf (IJH)
Schwab Strategic Tr Us Lcap Va Etf (SCHV)

View all positions for Koesten, Hirschmann & Crabtree

Top funds holding Adaptimmune Therapeutics

Long Focus Capital Management
UBS Group
Morgan Stanley
Renaissance Technologies
Jane Street
Acadian Asset Management
Empirical Finance
National Asset Management
Rathbones Brothers
FMR
Susquehanna International
Citadel Advisors
Lumbard Investment Counseling
Lakeridge Wealth Management
XTX Topco

View all funds holding Adaptimmune Therapeutics